USTR Extends Section 301 Exclusions for 81 Covid-19 Related Products

Posted on Nov 11


USTR Extends Section 301 Exclusions for 81 Covid-19 Related Products

The Office of the United States Trade Representative (USTR) has announced that they will further extend the Section 301 exclusions for 81 Covid-19 related medical products. Those 81 exclusions, which were part of a larger group of 99 exclusions that were originally set to expire on 11/14/21, will now be extended until May 31, 2022. The remaining 18 exclusions will not be renewed and will expire now on 11/30/21. A copy of the complete USTR announcement which lists all of the 81 affected items can be found here.

V. Alexander will continue to monitor this issue and provide updates as needed.

Please contact your V. Alexander account team with any questions and follow us on our website for updates on this and other topics.

SECURITY NOTICE: This web post may include hyperlinks to websites outside of our internal control. All hyperlinks in this web post are believed to be legitimate and provided for your convenience, however, we cannot take any responsibility for the safety of outside links. We recommend caution as with any hyperlinks in any web post, and to hover your mouse over the links before clicking to insure the destination is as expected or to visit the sites by going to the main websites for the agencies we reference in your web browser and search for the sites for the mentioned topics from there.